MedTrace Logo

Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice

NCT03199794 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-07-21

No results posted yet for this study

Summary

The study addresses the safety, utilisation and effectiveness of Obizur in the treatment of bleeding episodes in real-life clinical practice in Europe and the United States.

Conditions

  • Acquired Hemophilia A

Interventions

BIOLOGICAL

OBIZUR

Treating physician will determine treatment regimen and frequency of laboratory and clinical assessments according to routine clinical practice.

Sponsors & Collaborators

  • Baxalta Innovations GmbH, now part of Shire

    collaborator INDUSTRY

  • Baxalta now part of Shire

    lead INDUSTRY

Principal Investigators

  • Study Director · Shire

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-14
Primary Completion
2021-07-30
Completion
2021-07-30

Countries

  • United States
  • Austria
  • France
  • Germany
  • Italy
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03199794 on ClinicalTrials.gov